Header Logo

Search Result Details

Back to Search Results
This page shows the details of why an item matched the keywords from your search.
Search Results
Singh, Pankaj
One or more keywords matched the following items that are connected to Singh, Pankaj
Item TypeName
Concept Protein Kinase Inhibitors
Academic Article Chemotherapeutics-resistance "arms" race: An update on mechanisms involved in resistance limiting EGFR inhibitors in lung cancer.
Academic Article Combination of ERK and autophagy inhibition as a treatment approach for pancreatic cancer.
Academic Article Molecular dynamics and integrated pharmacophore-based identification of dual [Formula: see text] inhibitors.
Academic Article YAP1-Mediated CDK6 Activation Confers Radiation Resistance in Esophageal Cancer - Rationale for the Combination of YAP1 and CDK4/6 Inhibitors in Esophageal Cancer.
Academic Article Molecular dynamics guided development of indole based dual inhibitors of EGFR (T790M) and c-MET.
Academic Article Design and development of PEGylated liposomal formulation of HER2 blocker Lapatinib for enhanced anticancer activity and diminished cardiotoxicity.
Academic Article Structure based designing of triazolopyrimidone-based reversible inhibitors for kinases involved in NSCLC.
Academic Article Pharmacophore and molecular dynamics based activity profiling of natural products for kinases involved in lung cancer.
Academic Article Putative dual inhibitors of Janus kinase 1 and 3 (JAK1/3): Pharmacophore based hierarchical virtual screening.
Academic Article Identifying novel putative ERK1/2 inhibitors via hybrid scaffold hopping -FBDD approach.
Academic Article Kinases inhibitors in lung cancer: From benchside to bedside.
Academic Article Novel EGFR (T790M)-cMET dual inhibitors: putative therapeutic agents for non-small-cell lung cancer.
Academic Article Pharmacophore-based designing of putative ROS-1 targeting agents for NSCLC.
Academic Article Potential role for protein kinase D inhibitors in prostate cancer.
Academic Article Chitosan functionalized PCL nanoparticles bearing tyrosine kinase inhibitor osimertinib mesylate for effective lung cancer therapy.
Search Criteria
  • Protein Kinase Inhibitors